Page 2 - Vista Pharmaceuticals News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Vista pharmaceuticals. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Vista Pharmaceuticals Today - Breaking & Trending Today

HC Wainwright Trims KalVista Pharmaceuticals (NASDAQ:KALV) Target Price to $20.00

KalVista Pharmaceuticals (NASDAQ:KALV – Free Report) had its price objective reduced by HC Wainwright from $24.00 to $20.00 in a research report report published on Friday morning, Benzinga reports. They currently have a buy rating on the specialty pharmaceutical company’s stock. Separately, Needham & Company LLC reiterated a buy rating and set a $35.00 price […] ....

United States , New York , Benjaminl Palleiko , Kalvista Pharmaceuticals Company Profile , Kalvista Pharmaceuticals Price Performance , China Universal Asset Management Co , Tower Research Capital , Kalvista Pharmaceuticals , York State Common Retirement Fund , News Ratings For Kalvista Pharmaceuticals Daily , Hedge Funds Weigh In On Kalvista Pharmaceuticals , Needham Company , Securities Exchange Commission , Kalvista Pharmaceuticals Inc , Free Report , Vista Pharmaceuticals , Get Free Report , Venrock Healthcare Capital Par , Exchange Commission , Research Capital , Universal Asset Management , New York State Common Retirement Fund , Kalvista Pharmaceuticals Daily , Nasdaq Kalv , Lower Price Target , Hc Wainwright ,

KalVista Pharmaceuticals (NASDAQ:KALV) Price Target Cut to $20.00

KalVista Pharmaceuticals (NASDAQ:KALV) Price Target Cut to $20.00
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United States , Benjaminl Palleiko , Kalvista Pharmaceuticals , News Ratings For Kalvista Pharmaceuticals Daily , Nan Fung Group Holdings Ltd , Frazier Life Sciences Management , Kalvista Pharmaceuticals Company Profile , Needham Company , Sg Americas Securities , Affinity Asset Advisors , Kalvista Pharmaceuticals Stock Down , Kalvista Pharmaceuticals Inc , Insider Transactions At Kalvista Pharmaceuticals , Securities Exchange Commission , Vanguard Group Inc , Get Free Report , Vista Pharmaceuticals Stock Down , Vista Pharmaceuticals , Exchange Commission , Venrock Healthcare Capital Par , Asset Advisors , Fung Group Holdings Ltd , Kalvista Pharmaceuticals Daily ,

Analysts' Price Target Changes for May 3rd (AAPL, ACHR, AGCO, AIN, ALHC, ANGI, APPN, ASND, ASPN, BFAM)

Analysts’ price target changes for Friday, May 3rd: Apple (NASDAQ:AAPL) had its target price increased by Canaccord Genuity Group Inc. from $200.00 to $215.00. The firm currently has a buy rating on the stock. Archer Aviation (NYSE:ACHR) had its price target lowered by JPMorgan Chase & Co. from $7.00 to $5.00. They currently have an […] ....

United States , Sanfordc Bernstein , Ascendis Pharma , Janus Henderson Group , Intercontinental Exchange , Apple Inc , Reinsurance Group Of America , Canaccord Genuity Group Inc , Cyberark Software , Wells Fargo Company , Werner Enterprises , Quanta Services , Alliance Global Partners , Bright Horizons Family Solutions , Dominion Energy , Insight Enterprises , Digital Realty Trust , Church Dwight , Kalvista Pharmaceuticals , News Ratings For Apple Inc Daily , Expedia Group , Mohawk Industries , Soffa Industries , Motorola Solutions , Barrington Research , Eversource Energy ,

KalVista Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(4)

CAMBRIDGE, SALISBURY - KalVista Pharmaceuticals, Inc. , today announced that the compensation committee of KalVista s board of directors granted ten newly-hired employees inducement options to. ....

United Kingdom , Mashonaland East , Jarrod Aldom , Bryan Baker , Kalvista Pharmaceuticals Inc , Drug Administration , Vista Pharmaceuticals , Nasdaq Listing Rule , Inducement Equity Incentive Plan , News Publishing ,

KalVista Pharmaceuticals (NASDAQ:KALV) Receives "Buy" Rating from Needham & Company LLC

KalVista Pharmaceuticals (NASDAQ:KALV) Receives "Buy" Rating from Needham & Company LLC
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

United States , Benjaminl Palleiko , Edwardp Feener , Institutional Investors Weigh In On Kalvista Pharmaceuticals , Needham Company , Kalvista Pharmaceuticals Inc , Frazier Life Sciences Management , Vanguard Group Inc , Kalvista Pharmaceuticals Trading , Affinity Asset Advisors , Securities Exchange Commission , News Ratings For Kalvista Pharmaceuticals Daily , Nan Fung Group Holdings Ltd , Kalvista Pharmaceuticals , Sg Americas Securities , Free Report , Vista Pharmaceuticals , Get Free Report , Exchange Commission , Asset Advisors , Fung Group Holdings Ltd , Kalvista Pharmaceuticals Daily ,